MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
LivaNova PLC Operating Income 2011-2026 | LIVN
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income LivaNova PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 199 M | 129 M | -68.5 M | -76.8 M | -784 K | -274 M | -172 M | -248 M | 96.5 M | 33.4 M | 88.7 M | 80 M | 78.3 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 199 M | -274 M | -10.3 M |
Quarterly Operating Income LivaNova PLC
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54 M | 54.2 M | 48.6 M | - | 35.6 M | 40.2 M | 16.2 M | - | 4.46 M | 17.4 M | -2.34 M | - | -132 M | 31.8 M | 9.5 M | 24.8 M | 16.4 M | -36.3 M | -5.7 M | -249 M | -7.55 M | -16.7 M | -15.2 M | -144 M | 25.8 M | -29.9 M | -20.8 M | -276 M | -5.76 M | 21.6 M | 12.5 M | 18.9 M | 30 M | 27.8 M | 19.7 M | -14.9 M | 30.4 M | 25 M | -9.07 M | - | -26.4 M | -26.4 M | 16.7 M | - | 26.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 54.2 M | -276 M | -10.3 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
608 M | $ 173.14 | -0.8 % | $ 13 B |  USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 279.25 | 0.63 % | $ 7.88 B | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 10.9 | -1.54 % | $ 1.64 B | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.17 | -0.41 % | $ 1.64 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.61 | 0.84 % | $ 38 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.3 | -1.79 % | $ 124 M |  France |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 37.59 | -1.03 % | $ 5.6 K | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 61.79 | 0.83 % | $ 91.5 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.89 | - | $ 1.15 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.0 | -3.86 % | $ 16.9 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 8.68 | -3.12 % | $ 246 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 24.12 | -1.19 % | $ 204 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 15.97 | 0.19 % | $ 375 M | USA |
 |
Inogen
INGN
|
-30.2 M | $ 6.33 | -4.95 % | $ 168 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.7 | 4.4 % | $ 68.2 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
480 M | $ 90.42 | -1.07 % | $ 12.2 B | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.11 | -0.96 % | $ 870 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 10.04 | 1.62 % | $ 360 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.69 | -1.43 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 54.02 | -4.71 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.74 | -0.51 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 85.11 | -1.8 % | $ 2.96 B | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.68 | 0.38 % | $ 122 M | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 77.87 | -1.62 % | $ 45.5 B | USA |